Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital.
about
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): a perpetual challengeThe effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysisSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionPhysiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattleUse of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.A review of treatment modalities for Middle East Respiratory Syndrome.Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolConvalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.Advances in antivirals for non-influenza respiratory virus infections.The management of coronavirus infections with particular reference to SARS.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseTriple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production.History of passive antibody administration for prevention and treatment of infectious diseases.Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.Chronic beta-AR activation-induced calpain activation and impaired eNOS-Akt signaling mediates cardiac injury in ovariectomized female rats.[Position on blood collection and use of convalescent plasma as a treatment option in the outbreak of severe infections].Avian influenza: recent epidemiology, travel-related risk, and management.Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.
P2860
Q26999367-3268AA55-649A-4452-A369-FE5B7ECC7874Q27001157-CF26D217-67D4-418A-BA16-03C58220A3FBQ28383088-141826D0-CD6D-4A05-9EC1-2DDC0F2C80DDQ28534719-5736B51F-B07A-4BC1-B909-D8539D1C32ECQ30145641-7BCD77CE-49B6-40CE-ADDF-E74AE42740E7Q30248209-4A0AB25A-D890-48A1-A2DE-B35E60CB540EQ30277992-F6C36F80-3FEB-43F4-B1AA-7DCE866F33C9Q30398715-3FF914D5-5C57-4D8F-94AE-7177B9548B51Q30457132-A5C2205B-6EB8-421D-B604-70407C9F1A4DQ34012358-00C24A94-1F4C-45B5-A35C-CEF07608A003Q34468689-BB7917CB-360B-45F3-B409-13302476C2A9Q35112982-759BDCD6-6660-4D05-A581-496F0D85BE0DQ35624143-67E1C422-A85A-4786-8788-3EFD2DE579C7Q37366744-39E90988-F0E0-455F-A5EE-145685CDC53BQ37486435-C0C13A5B-88CC-440C-A19D-F14F6EA7F4CDQ40134490-1CDF1979-47C2-4234-9FF1-E9F5726D6E3BQ41617539-CCA8F9EE-5DCB-4CB6-BD7C-2FFC6F691C7BQ47656792-9A32CE32-44C8-409D-B290-883E195F3682
P2860
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Experience of using convalesce ...... workers in a Taiwan hospital.
@en
Experience of using convalesce ...... workers in a Taiwan hospital.
@nl
type
label
Experience of using convalesce ...... workers in a Taiwan hospital.
@en
Experience of using convalesce ...... workers in a Taiwan hospital.
@nl
altLabel
Experience of using convalesce ...... e workers in a Taiwan hospital
@en
prefLabel
Experience of using convalesce ...... workers in a Taiwan hospital.
@en
Experience of using convalesce ...... workers in a Taiwan hospital.
@nl
P2093
P2860
P356
P1476
Experience of using convalesce ...... workers in a Taiwan hospital.
@en
P2093
Bor-Shen Hu
Cherng-Lih Perng
Feng-Yee Chang
Hsiang-Lin Wan
Jang-Jih Lu
Jenn-Han Chen
Jung-Chung Lin
Kuo-Ming Yeh
Ming-Yieh Peng
P2860
P304
P356
10.1093/JAC/DKI346
P407
P577
2005-09-23T00:00:00Z